Revised SPCs: Cosopt (dorzolamide hydrochloride, timolol maleate) 20 mg/ml + 5 mg/ml eye drops – all products

SPC updated to include hallucination, foreign body sensation in eye, palpitations and dyspnoea as adverse effects of treatment with unknown frequency.

electronic Medicines compendium